Recent applications of quantitative systems pharmacology and machine learning models across diseases

被引:35
作者
Aghamiri, Sara Sadat [1 ]
Amin, Rada [1 ]
Helikar, Tomas [1 ]
机构
[1] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA
关键词
Systems biology; Quantitative systems pharmacology; Predictive models; Machine learning; Immuno-oncology; Immunotherapy; DRUG DISCOVERY; PREDICTION; NETWORK; CLASSIFICATION; HOMEOSTASIS; MANAGEMENT; ALGORITHM; BIOLOGY; RISK; BONE;
D O I
10.1007/s10928-021-09790-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quantitative systems pharmacology (QSP) is a quantitative and mechanistic platform describing the phenotypic interaction between drugs, biological networks, and disease conditions to predict optimal therapeutic response. In this meta-analysis study, we review the utility of the QSP platform in drug development and therapeutic strategies based on recent publications (2019-2021). We gathered recent original QSP models and described the diversity of their applications based on therapeutic areas, methodologies, software platforms, and functionalities. The collection and investigation of these publications can assist in providing a repository of recent QSP studies to facilitate the discovery and further reusability of QSP models. Our review shows that the largest number of QSP efforts in recent years is in Immuno-Oncology. We also addressed the benefits of integrative approaches in this field by presenting the applications of Machine Learning methods for drug discovery and QSP models. Based on this meta-analysis, we discuss the advantages and limitations of QSP models and propose fields where the QSP approach constitutes a valuable interface for more investigations to tackle complex diseases and improve drug development.
引用
收藏
页码:19 / 37
页数:19
相关论文
共 160 条
[91]   A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade [J].
Milberg, Oleg ;
Gong, Chang ;
Jafarnejad, Mohammad ;
Bartelink, Imke H. ;
Wang, Bing ;
Vicini, Paolo ;
Narwal, Rajesh ;
Roskos, Lorin ;
Popel, Aleksander S. .
SCIENTIFIC REPORTS, 2019, 9 (1)
[92]   A mathematical model to identify optimal combinations of drug targets for dupilumab poor responders in atopic dermatitis [J].
Miyano, Takuya ;
Irvine, Alan D. ;
Tanaka, Reiko J. .
ALLERGY, 2022, 77 (02) :582-594
[93]  
Mnih Andriy, 2008, P NIPS, P1257
[94]   CancerDiscover: an integrative pipeline for cancer biomarker and cancer class prediction from high-throughput sequencing data [J].
Mohammed, Akram ;
Biegert, Greyson ;
Adamec, Jiri ;
Helikar, Tomas .
ONCOTARGET, 2018, 9 (02) :2565-2573
[95]   Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers [J].
Mohammed, Akram ;
Biegert, Greyson ;
Adamec, Jiri ;
Helikar, Tomas .
ONCOTARGET, 2017, 8 (49) :85692-85715
[96]   Mechanistic evaluation of the effect of sodium-dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus using a quantitative systems pharmacology model of human systemic glucose dynamics [J].
Mori-Anai, Kazumi ;
Tashima, Yoshihiko ;
Nakada, Tomohisa ;
Nakamaru, Yoshinobu ;
Takahata, Takayuki ;
Saito, Ryuta .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2020, 41 (8-9) :352-366
[97]   Clinical Challenges in the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Literature Review [J].
Nagaraj, Gayathri ;
Ma, Cynthia X. .
ADVANCES IN THERAPY, 2021, 38 (01) :109-136
[98]   Leveraging Quantitative Systems Pharmacology Approach into Development of Human Recombinant Follistatin Fusion Protein for Duchenne Muscular Dystrophy [J].
Nguyen, Hoa Q. ;
Iskenderian, Andrea ;
Ehmann, David ;
Jasper, Paul ;
Zhang, Zhiwei ;
Rong, Haojing ;
Welty, Devin ;
Narayanan, Rangaraj .
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (06) :342-352
[99]   A practical guide to mechanistic systems modeling in biology using a logic-based approach [J].
Niarakis, Anna ;
Helikar, Tomas .
BRIEFINGS IN BIOINFORMATICS, 2021, 22 (04)
[100]   Preclinical QSP Modeling in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape [J].
Nijsen, Marjoleen J. M. A. ;
Wu, Fan ;
Bansal, Loveleena ;
Bradshaw-Pierce, Erica ;
Chan, Jason R. ;
Liederer, Bianca M. ;
Mettetal, Jerome T. ;
Schroeder, Patricia ;
Schuck, Edgar ;
Tsai, Alice ;
Xu, Christine ;
Chimalakonda, Anjaneya ;
Le, Kha ;
Penney, Mark ;
Topp, Brian ;
Yamada, Akihiro ;
Spilker, Mary E. .
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2018, 7 (03) :135-146